<?xml version="1.0"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v2.3 20070202//EN" "archivearticle.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article">
  <?DTDIdentifier.IdentifierValue -//ES//DTD journal article DTD version 5.1.0//EN//XML?>
  <?DTDIdentifier.IdentifierType public?>
  <?SourceDTD.DTDName art510.dtd?>
  <?SourceDTD.Version 5.1.0?>
  <?ConverterInfo.XSLTName elsevier2nlm.xsl?>
  <?ConverterInfo.Version 1?>
  <?origin publisher?>
  <?FILEmeta_HIM8390 xml ?>
  <?FILEmain xml ?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Hum Immunol</journal-id>
      <journal-title>Human Immunology</journal-title>
      <issn pub-type="ppub">0198-8859</issn>
      <issn pub-type="epub">1879-1166</issn>
      <publisher>
        <publisher-name>Elsevier/North-Holland</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmc">2837141</article-id>
      <article-id pub-id-type="pmid">20074603</article-id>
      <article-id pub-id-type="publisher-id">HIM8390</article-id>
      <article-id pub-id-type="doi">10.1016/j.humimm.2010.01.008</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Article</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title><italic>APOE</italic> polymorphism and its effect on plasma C-reactive protein levels in a large general population sample</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Hubacek</surname>
            <given-names>Jaroslav A.</given-names>
          </name>
          <xref rid="aff1" ref-type="aff">a</xref>
          <xref rid="aff2" ref-type="aff">b</xref>
          <xref rid="aff3" ref-type="aff">c</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Peasey</surname>
            <given-names>Anne</given-names>
          </name>
          <xref rid="aff4" ref-type="aff">d</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Pikhart</surname>
            <given-names>Hynek</given-names>
          </name>
          <xref rid="aff4" ref-type="aff">d</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Stavek</surname>
            <given-names>Petr</given-names>
          </name>
          <xref rid="aff1" ref-type="aff">a</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Kubinova</surname>
            <given-names>Ruzena</given-names>
          </name>
          <xref rid="aff5" ref-type="aff">e</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Marmot</surname>
            <given-names>Michael</given-names>
          </name>
          <xref rid="aff4" ref-type="aff">d</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Bobak</surname>
            <given-names>Martin</given-names>
          </name>
          <email>m.bobak@ucl.ac.uk</email>
          <xref rid="aff4" ref-type="aff">d</xref>
          <xref rid="cor1" ref-type="corresp">&#x204E;</xref>
        </contrib>
      </contrib-group>
      <aff id="aff1">
        <addr-line><sup>a</sup>Institute of Clinical and Experimental Medicine, Prague, Czech Republic</addr-line>
      </aff>
      <aff id="aff2">
        <addr-line><sup>b</sup>Centre for Cardiovascular Research, Prague, Czech Republic</addr-line>
      </aff>
      <aff id="aff3">
        <addr-line><sup>c</sup>South Bohemia University, Faculty of Public Health and Social Studies, Ceske Budejovice, Czech Republic</addr-line>
      </aff>
      <aff id="aff4">
        <addr-line><sup>d</sup>Department of Epidemiology and Public Health, University College London, London, UK</addr-line>
      </aff>
      <aff id="aff5">
        <addr-line><sup>e</sup>National Institute of Public Health, Prague, Czech Republic</addr-line>
      </aff>
      <author-notes>
        <corresp id="cor1"><label>&#x204E;</label>Corresponding author <email>m.bobak@ucl.ac.uk</email></corresp>
      </author-notes>
      <pub-date pub-type="ppub">
        <month>3</month>
        <year>2010</year>
      </pub-date>
      <volume>71</volume>
      <issue>3</issue>
      <fpage>304</fpage>
      <lpage>308</lpage>
      <history>
        <date date-type="received">
          <day>28</day>
          <month>5</month>
          <year>2009</year>
        </date>
        <date date-type="accepted">
          <day>7</day>
          <month>1</month>
          <year>2010</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xC2;&#xA9; 2010 Elsevier Inc..</copyright-statement>
        <copyright-year>2010</copyright-year>
        <copyright-holder>American Society for Histocompatibility and Immunogenetics</copyright-holder>
        <license>
          <p>This document may be redistributed and reused, subject to <ext-link ext-link-type="uri" xlink:href="http://www.elsevier.com/wps/find/authorsview.authors/supplementalterms1.0">certain conditions</ext-link>.</p>
        </license>
      </permissions>
      <abstract>
        <title>Abstract</title>
        <p>The published data remain inconsistent on association between apolipoprotein E (<italic>APOE</italic>) gene variations and plasma levels of C-reactive protein (CRP), mainly because of low statistical power of previous studies. To clarify this question, we analyzed data from large population sample of randomly selected individuals from seven Czech towns (2,886 males and 3,344 females, the HAPIEE [Health, Alcohol, and Psychosocial factors In Eastern Europe] study). In both males and females, the lowest levels of plasma hsCRP were observed in the carriers of the <italic>APOE &#x3B5;4&#x3B5;4</italic> and <italic>&#x3B5;4&#x3B5;3</italic> genotypes. The median (interquartile range, IQR) concentration of hsCRP in carriers of the most common <italic>APOE &#x3B5;3&#x3B5;3</italic> genotype (two-thirds of participants) was 1.13 mg/l (IQR, 0.56&#x2013;2.33) in men and 1.23 mg/l (IQR, 0.61&#x2013;2.65) in women, compared with 0.72 mg/l (IQR, 0.61&#x2013;0.86) in male and 0.72 mg/l (IQR, 0.61&#x2013;0.85) in female carriers of <italic>APOE &#x3B5;4&#x3B5;3/&#x3B5;4&#x3B5;4</italic> genotypes; the differences were statistically significant (<italic>p</italic> &lt; 0.001). The association between <italic>APOE</italic> and CRP was not materially affected by adjustment for age, sex, history of cardiovascular disease, or cardiovascular risk factors. This study, the largest to date, provides robust evidence of an association between plasma hsCRP and the <italic>APOE</italic> genotype, an association not explained by history of cardiovascular disease nor its risk factors.</p>
      </abstract>
      <kwd-group>
        <title>Keywords</title>
        <kwd>
          <italic>APOE</italic>
        </kwd>
        <kwd>C-reactive protein</kwd>
        <kwd>Polymorphism</kwd>
        <kwd>Population study</kwd>
        <kwd>Inflammation</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec id="sec1">
      <label>1</label>
      <title>Introduction</title>
      <p>There is extensive published data on the potential effect of low-grade inflammation in the vascular endothelium on atherosclerosis development <xref rid="bib1" ref-type="bibr">[1]</xref>. C-reactive protein (CRP), the acute phase serum protein produced by liver, has often been used as an overall marker of inflammation. Elevated plasma levels of CRP have been repeatedly found in patients with cardiovascular disease (CVD) and myocardial infarction, and it has been proposed that CRP is an independent risk factor of CVD <xref rid="bib2 bib3" ref-type="bibr">[2,3]</xref>, although the pathogenic and clinical significance of CRP remains controversial <xref rid="bib4" ref-type="bibr">[4]</xref>. In addition to CVD, plasma levels of CRP have been also found to correlate with CVD risk factors, such as body mass index (BMI), lipid parameters, smoking, and dietary habits <xref rid="bib5" ref-type="bibr">[5]</xref>. Similarly to other risk factors of atherosclerosis development, plasma levels of CRP are partially genetically determined <xref rid="bib6 bib7 bib8 bib9" ref-type="bibr">[6&#x2013;9]</xref>.</p>
      <p>Apolipoprotein E (<italic>APOE</italic>, gene ID 348, OMIM acc Number 107741) is a multifunctional protein that plays a key role in the metabolism of plasma lipids and is found on the surface of the triglyceride rich lipoproteins. Three common <italic>APOE</italic> alleles (&#x3B5;<italic>2</italic>, <italic>&#x3B5;3</italic>, and <italic>&#x3B5;4</italic>) and many rare mutations have been described; the frequencies of these variants differ between populations <xref rid="bib10 bib11 bib12 bib13" ref-type="bibr">[10&#x2013;13]</xref>. In general, individuals carrying the <italic>&#x3B5;4</italic> allele [Cys112 &#x2192; Arg, rs429358] have higher total cholesterol levels and persons carrying the <italic>&#x3B5;2</italic> allele [Arg158 &#x2192; Cys, rs7412] have lower cholesterol than those carrying the most common <italic>&#x3B5;3&#x3B5;3</italic> genotype. The role of the apolipoprotein E, regulated by the <italic>APOE</italic> gene, in the inflammatory response has also been suggested <xref rid="bib14" ref-type="bibr">[14]</xref>, and there is some evidence to support such an effect from studies in both animal models and humans <xref rid="bib14 bib15" ref-type="bibr">[14,15]</xref>. Although data on individual variants are not entirely consistent, a pro-inflammatory state seems associated with <italic>APOE &#x3B5;4</italic> allele <xref rid="bib14" ref-type="bibr">[14]</xref>; the same allele is associated with severe sepsis in surgical patients <xref rid="bib16" ref-type="bibr">[16]</xref>.</p>
      <p>A possible, but physiologically unexplained, association has been suggested between the common <italic>APOE</italic> polymorphism and plasma level of CRP. However, the results to date are contradictory. Although initial observations suggested that the highest plasma levels of CRP are in <italic>APOE &#x3B5;3/e3</italic> carriers and the lowest levels in <italic>APOE &#x3B5;4/e4</italic> and <italic>APOE &#x3B5;4/e2</italic> carriers <xref rid="bib17" ref-type="bibr">[17]</xref>, subsequent studies were not entirely consistent, as shown in <xref rid="tbl1" ref-type="table">Table 1</xref> <xref rid="bib18 bib19 bib20 bib21 bib22 bib23 bib24 bib25 bib26 bib27 bib28 bib29 bib30 bib31 bib32 bib33 bib34 bib35" ref-type="bibr">[18&#x2013;35]</xref>. A large part of the apparent inconsistencies is due to the very low statistical power of most studies (with a few exceptions), the use of various preselected subgroups (<italic>e.g.</italic>, patients with dyslipidemias or CVD, diabetics, or elderly subjects) and unclear methodology. Clarification of the association between <italic>APOE</italic> genotype and CRP is important for at least two reasons. First, the biologic mechanisms responsible for the association between <italic>APOE</italic> genotype and CVD remain unclear; examining whether associations between <italic>APOE</italic> and potential cardiovascular risk factors (such as CRP) mirror the association of <italic>APOE</italic> with CVD is, therefore, helpful in elucidating the causal pathway. Second, it has long been recognized that apolipoprotein E, and <italic>APOE</italic> genotype, affect a broad range of biologic functions <xref rid="bib36" ref-type="bibr">[36]</xref>, and there is interest in the effects of <italic>APOE</italic> on inflammatory response rate <xref rid="bib14" ref-type="bibr">[14]</xref>.</p>
      <p>In this article, we used data from a large population-based study with sufficient statistical power, to investigate differences in plasma CRP levels by <italic>APOE</italic> genotype, and whether such differences can be explained by history of CVD or its risk factors.</p>
    </sec>
    <sec id="sec2">
      <label>2</label>
      <title>Subjects and methods</title>
      <sec id="sec2.1">
        <label>2.1</label>
        <title>Study subjects</title>
        <p>We used data from the Czech part of the HAPIEE (Health, Alcohol, and Psychosocial factors In Eastern Europe) study. Details of the study have been described elsewhere <xref rid="bib37" ref-type="bibr">[37]</xref>. Briefly, random population samples of men and women aged 45&#x2013;69 years from seven Czech towns (Jihlava, Havirov, Hradec Kralov&#xE9;, Karvina, Kromeriz, Liberec, and Ust&#xED; nad Labem) were invited to complete a questionnaire and to attend an examination in a clinic. A total of 8,856 persons completed the questionnaire (response rate: 55%), of whom 7,260 attended the examination, 6,920 provided blood sample, and DNA sample was available on 6,748 individuals.</p>
      </sec>
      <sec id="sec2.2">
        <label>2.2</label>
        <title>Measurements</title>
        <p>High-sensitivity (hs) CRP was measured immunoturbidimetrically by the WHO Lipid Reference Centre in Prague, using the Roche COBAS (Mannheim, Germany), MIRA autoanalyzer and reagents from Orion Diagnostica, Espoo, Finland (kit no. 68025). DNA was isolated from frozen whole blood using the standard salting-out method <xref rid="bib38" ref-type="bibr">[38]</xref>. Genotyping of the <italic>APOE</italic> gene was performed as described previously <xref rid="bib39" ref-type="bibr">[39]</xref>. The frequencies of the individual genotypes are similar to findings in neighboring populations <xref rid="bib11" ref-type="bibr">[11]</xref>, and deviation from the Hardy&#x2013;Weinberg equilibrium was not statistically significant (<italic>p</italic>-values were 0.13 in men, 0.22 in women, and 0.07 in both genders combined). In seven individuals, a rare <italic>APOE</italic> mutation Arg136Cys was detected <xref rid="bib40" ref-type="bibr">[40]</xref>, and these individuals were excluded from the study. In further 73 individuals, the genotyping failed even when repeated three times. A total of 6,492 persons had valid data, both on CRP level and <italic>APOE</italic> genotype.</p>
      </sec>
      <sec id="sec2.3">
        <label>2.3</label>
        <title>Statistical analyses</title>
        <p>We further excluded subjects who had hsCRP &#x2265; 10 mg/l CRP levels (<italic>n</italic> = 262) from the analysis because of a possible acute infection. The present analyses are thus based on 6,230 subjects (2,886 males and 3,344 females) with full data on CRP and <italic>APOE</italic> and with hsCRP concentrations &lt;10 mg/l.</p>
        <p>Because the distribution of hsCRP levels is highly skewed, to the extent that even logarithmically transformed values are highly asymmetrically distributed, we used nonparametric methods. First, we show, for each <italic>APOE</italic> genotype, and within each sex, the median and interquartile range (IQR) of hsCRP concentrations. Second, crude differences in hsCRP levels by <italic>APOE</italic> genotype were assessed by the Kruskal&#x2013;Wallis nonparametric test, separately for men and women. Finally, because the differences in hsCRP by <italic>APOE</italic> genotypes were similar in men and women, data from both genders were pooled, and the relationship between <italic>APOE</italic> genotype and quartile of hsCRP was estimated using ordered logistic regression. This approach, while not making assumption about the distribution of CRP, allows multivariate analysis and therefore adjustment for covariates; we controlled for age, sex, history of myocardial infarction, angina and stroke (each coded as 0/1), current smoking, total cholesterol, BMI (kg/m<sup>2</sup>), and hypertension (systolic/diastolic blood pressure &#x2265;140/85 mm Hg or antihypertensive medication in the last 2 weeks). The odds ratio derived from ordered logistic regression can be interpreted as the weighted mean of (i) odds of CRP quartile 1 vs. quartiles 2&#x2013;4, (ii) odds of quartiles 1&#x2013;2 vs. quartiles 3&#x2013;4, and (iii) odds of quartiles 1&#x2013;3 vs. quartile 4, associated with a given genotype. The proportional odds assumption was fulfilled (the <italic>p</italic>-value from the approximate likelihood-ratio test of proportionality of odds across CRP quartile response categories was 0.133).</p>
      </sec>
    </sec>
    <sec id="sec3">
      <label>3</label>
      <title>Results</title>
      <p>Descriptive characteristics of the subjects included in the analysis are summarized in <xref rid="tbl2" ref-type="table">Table 2</xref>. The median CRP levels were slightly higher in men than in women (<italic>p</italic> &lt; 0.001) and, as expected, CRP was positively correlated with age, BMI, and smoking (not shown in table). The distribution of the <italic>APOE</italic> genotypes in individuals excluded because of CRP concentration &gt; =10 mg/l did not differ from the general population (<italic>APOE &#x3B5;2&#x3B5;2</italic> 0.8%, <italic>APOE &#x3B5;2&#x3B5;3</italic> 13.7%, <italic>APOE &#x3B5;3&#x3B5;3</italic> 65.3%, <italic>APOE &#x3B5;4&#x3B5;3</italic> 16.8%, <italic>APOE &#x3B5;4&#x3B5;2</italic> 2.7%, and <italic>APOE &#x3B5;4&#x3B5;4</italic> 0.8%, not shown in table).</p>
      <p>The plasma levels hsCRP by the <italic>APOE</italic> genotypes are summarized in <xref rid="tbl3" ref-type="table">Table 3</xref>. Serum levels of hsCRP differed highly significantly between <italic>APOE</italic> genotypes, both by all six individual genotypes and by four groups defined by the presence of the <italic>APOE</italic> alleles, that is, carriers of the <italic>APOE &#x3B5;2</italic> allele, <italic>APOE &#x3B5;3&#x3B5;3</italic> homozygotes, and <italic>APOE &#x3B5;4</italic> carriers. The <italic>APOE &#x3B5;2&#x3B5;4</italic> genotype is also reported separately because of the uncertainty about pooling with other genotypes. The differences were of similar magnitude in males and females. In males, <italic>APOE &#x3B5;3&#x3B5;3</italic> homozygotes had the highest median serum hsCRP; similarly, females with <italic>APOE &#x3B5;3&#x3B5;3</italic> genotype also had high CRP (only very slightly lower median than <italic>APOE &#x3B5;4&#x3B5;2</italic> heterozygotes); even in such a large study, however, the numbers of individuals with specific uncommon genotypes within each sex were insufficient to provide statistically reliable estimates of hsCRP levels.</p>
      <p>Given the similarity of associations in men and women (and the interactions between sex and <italic>APOE</italic> were not statistically significant), we pooled the data from both genders, and we used ordered logistic regression to assess the association between <italic>APOE</italic> genotype and hsCRP after controlling for covariates (<xref rid="tbl4" ref-type="table">Table 4</xref>). The associations remained strong and highly statistically significant after adjustment for the age, history of CVD, smoking, BMI, total cholesterol, and hypertension. In addition to lower hsCRP in the combined <italic>APOE &#x3B5;4</italic> group, both <italic>APOE &#x3B5;4&#x3B5;3</italic> and <italic>APOE &#x3B5;4&#x3B5;4</italic> genotypes had statistically lower levels of hsCRP than <italic>APOE &#x3B5;3&#x3B5;3</italic> homozygotes in these pooled analyses (because of increased statistical power, compared with sex-specific analyses).</p>
    </sec>
    <sec id="sec4">
      <label>4</label>
      <title>Discussion</title>
      <p>The present study, the largest on this subject to date, found that the serum hsCRP is independently determined by the common genetic polymorphisms within the <italic>APOE</italic> gene. Given the large size (and hence, high statistical power) of this study, these findings provide robust evidence that the <italic>APOE &#x3B5;4</italic> allele is associated with low levels of plasma hsCRP.</p>
      <p>Previous studies on this subject did not yield results that were not entirely consistent. In some populations, both <italic>&#x3B5;2</italic> and <italic>&#x3B5;3</italic> carriers were reported to have the highest CRP <xref rid="bib17 bib18" ref-type="bibr">[17,18]</xref>. Some studies of elderly subjects showed either the highest levels of CRP in <italic>APOE &#x3B5;2</italic> carriers <xref rid="bib19 bib21" ref-type="bibr">[19,21]</xref> or no effect of <italic>APOE</italic> genotype on plasma CRP at all <xref rid="bib22" ref-type="bibr">[22]</xref>. A study in younger adult females found the highest hsCRP levels in carriers of the <italic>APOE &#x3B5;4</italic> allele <xref rid="bib23" ref-type="bibr">[23]</xref>. In a recent genome-wide association study, CRP levels had a significant genetic component and <italic>APOE</italic> was among genes detected to have a significant effect on plasma CRP; however, CRP values by the specific alleles were not available <xref rid="bib8" ref-type="bibr">[8]</xref>.</p>
      <p>The discrepancies in previous findings are mainly due to the low statistical power of most previous studies. In addition, many studies analyzed subjects who included patient's relatives or preselected subgroups, such as dyslipidemic subjects <xref rid="bib17 bib21 bib27" ref-type="bibr">[17,21,27]</xref>, ethnically nonhomogenous populations <xref rid="bib20" ref-type="bibr">[20]</xref>, the elderly <xref rid="bib19 bib22" ref-type="bibr">[19,22]</xref>, or families of patients <xref rid="bib24 bib26" ref-type="bibr">[24,26]</xref>. There were also methodological inconsistencies; for example, many papers do not specify whether extreme hsCRP levels were excluded from the analyses (because of the concerns about the presence of acute infection) or the grouping of <italic>APOE</italic> genotypes differs between papers. Inappropriate statistics may have also contributed to the heterogeneous findings&#x2014;most studies reported geometrical means of hsCRP but, given the extremely skewed distribution of hsCRP, the use of parametric methods is likely to produce misleading results. Overall, previous data mostly suggest low CRP levels in carriers of &#x3B5;4 compared with &#x3B5;3&#x3B5;3, but the inconsistencies in reporting allow neither reliable conclusions nor formal meta-analysis without obtaining the raw data.</p>
      <p>Our study overcame many of these limitations. First, its size (roughly equivalent to half of all previous published studies combined) provided sufficient statistical power to study not only groups of genotypes, but specific genotypes separately. Second, contrary to many previous investigations, our study recruited a random general (and ethnically homogenous) population sample, rather than patients selected for a particular condition, such as candidates for statin treatment, diabetics, or different ethnicities. Third, our study sample was slightly younger than many previous studies (the mean age in many studies was considerably higher than sixty years); as age is an important predictor of CRP, studies in younger subjects are particularly useful. Fourth, we excluded subjects with high CRP levels, and thus limited misclassification because of possible acute infection, and used nonparametric methods that do not make assumptions about distribution of CRP. Finally, our subjects were phenotypically well characterized, enabling us to discount history of CVD and risk factors for CVD as possible explanations for the relation between <italic>APOE</italic> genotype and hsCRP.</p>
      <p>The biologic basis for the relationship between <italic>APOE</italic> and hsCRP is not clear. Given that both plasma apolipoprotein E and CRP come from the same source in organism, the liver, the expression of these proteins could be regulated by similar factors, but no experimental evidence has been published so far.</p>
      <p>The present results, consistent with most previously published data, highlight an important contradiction. On the one hand, individuals with elevated levels of the hsCRP are at increased risk of mortality and morbidity from multiple disease states, including myocardial infarction, stroke, diabetes, metabolic syndrome <xref rid="bib3" ref-type="bibr">[3]</xref>, and end stage renal disease <xref rid="bib14" ref-type="bibr">[14]</xref>. By contrast, <italic>APOE &#x3B5;4</italic> is associated with increased risk of CVD and end stage renal disease <xref rid="bib41" ref-type="bibr">[41]</xref>. Yet, the CRP levels are lower in carriers of <italic>APOE</italic> &#x3B5;4, which is the &#x201C;risky&#x201D; genotype for CVD, and high concentrations of hsCRP, proposed to be a risk factor of CVD, are not associated with the <italic>APOE &#x3B5;4</italic> allele as would be expected. To complicate the situation further, there is an inverse association between plasma apolipoprotein E concentration and CRP levels <xref rid="bib42" ref-type="bibr">[42]</xref>, and plasma apolipoprotein concentrations seem to be higher in <italic>APOE &#x3B5;2</italic> carriers and lower in <italic>APOE &#x3B5;4</italic> carriers <xref rid="bib43" ref-type="bibr">[43]</xref>. This suggests that the effects of <italic>APOE</italic> and CRP operate by different and mutually independent mechanisms, or that the <italic>APOE</italic> genotype is associated with, but is not a causal determinant of plasma CRP levels.</p>
      <p>It is possible that slightly elevated CRP levels, based on genetic predisposition, rather than inflammatory status, account for the elevated risk of vascular disease. Indeed, a large prospective study has shown that variants in the CRP gene are associated with marked increase of CRP levels, but these polymorphisms were not associated with increased risk of vascular disease <xref rid="bib44" ref-type="bibr">[44]</xref>. This would allow for the possibility that adverse effects of increases in CRP levels are limited to inflammation induced environmentally, rather than genetically.</p>
      <p>Our study was not designed to investigate the important question of the etiological role of CRP in CVD. However, we have clearly demonstrated that the <italic>APOE</italic> genotype influences CRP concentrations. Future studies are needed to clarify the implication of this association for the risk of common diseases, such as vascular diseases.</p>
    </sec>
  </body>
  <back>
    <ack>
      <title>Acknowledgments</title>
      <p content-type="acknowledgment">The authors thank nurses in the Czech regional Health Institutes who collected the data. This work was supported by project No. 1M0510 from the Ministry of Health, Youth and Education of the Czech Republic; grant from Institute for Clinical and Experimental Medicine (00023001); grant from the Wellcome Trust &#x201C;Determinants of Cardiovascular Diseases in Eastern Europe: A multi-centre cohort study&#x201D; (Reference number 064947/Z/01/Z) and &#x201C;Determinants of Cardiovascular Diseases in Eastern Europe: Longitudinal follow-up of a multi-centre cohort study (The HAPIEE Project)&#x201D; (Reference number 081081/Z/06/Z); a grant from the National Institute on Aging &#x201C;Health disparities and aging in societies in transition (the HAPIEE study)&#x201D;, grant number 1R01 AG23522-01; and a grant from MacArthur Foundation &#x201C;Health and Social Upheaval (a research network)&#x201D;.</p>
    </ack>
    <ref-list>
      <title>References</title>
      <ref id="bib1">
        <label>[1]</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Shishehbor</surname>
              <given-names>M.H.</given-names>
            </name>
            <name>
              <surname>Bhatt</surname>
              <given-names>D.L.</given-names>
            </name>
          </person-group>
          <article-title>Inflammation and atherosclerosis</article-title>
          <source>Curr Atheroscler Rep</source>
          <year>2004</year>
          <volume>6</volume>
          <fpage>131</fpage>
          <lpage>139</lpage>
          <pub-id pub-id-type="pmid">15023298</pub-id>
        </citation>
      </ref>
      <ref id="bib2">
        <label>[2]</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lagrand</surname>
              <given-names>W.K.</given-names>
            </name>
            <name>
              <surname>Visser</surname>
              <given-names>C.A.</given-names>
            </name>
            <name>
              <surname>Hermens</surname>
              <given-names>W.T.</given-names>
            </name>
            <name>
              <surname>Niessen</surname>
              <given-names>H.W.</given-names>
            </name>
            <name>
              <surname>Verheugt</surname>
              <given-names>F.W.</given-names>
            </name>
            <name>
              <surname>Wolbink</surname>
              <given-names>G.J.</given-names>
            </name>
          </person-group>
          <article-title>C-reactive protein as a cardiovascular risk factor: More than an epiphenomenon?</article-title>
          <source>Circulation</source>
          <year>1999</year>
          <volume>100</volume>
          <fpage>96</fpage>
          <lpage>102</lpage>
          <pub-id pub-id-type="pmid">10393687</pub-id>
        </citation>
      </ref>
      <ref id="bib3">
        <label>[3]</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ridker</surname>
              <given-names>P.M.</given-names>
            </name>
          </person-group>
          <article-title>Inflammatory biomarkers and risks of myocardial infarction, stroke, diabetes, and total mortality: Implications for longevity</article-title>
          <source>Nutr Rev</source>
          <year>2007</year>
          <volume>65</volume>
          <fpage>S253</fpage>
          <lpage>S259</lpage>
          <pub-id pub-id-type="pmid">18240558</pub-id>
        </citation>
      </ref>
      <ref id="bib4">
        <label>[4]</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Casas</surname>
              <given-names>J.P.</given-names>
            </name>
            <name>
              <surname>Shah</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Hingorani</surname>
              <given-names>A.D.</given-names>
            </name>
            <name>
              <surname>Danesh</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Pepys</surname>
              <given-names>M.B.</given-names>
            </name>
          </person-group>
          <article-title>C-reactive protein and coronary heart disease: A critical review</article-title>
          <source>J Intern Med</source>
          <year>2008</year>
          <volume>264</volume>
          <fpage>295</fpage>
          <lpage>314</lpage>
          <pub-id pub-id-type="pmid">18823504</pub-id>
        </citation>
      </ref>
      <ref id="bib5">
        <label>[5]</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kushner</surname>
              <given-names>I.</given-names>
            </name>
            <name>
              <surname>Rzewnicki</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Samols</surname>
              <given-names>D.</given-names>
            </name>
          </person-group>
          <article-title>What does minor elevation of C-reactive protein signify?</article-title>
          <source>Am J Med</source>
          <year>2006</year>
          <volume>119</volume>
          <comment>166&#x2013;28</comment>
        </citation>
      </ref>
      <ref id="bib6">
        <label>[6]</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Danik</surname>
              <given-names>J.S.</given-names>
            </name>
            <name>
              <surname>Ridker</surname>
              <given-names>P.M.</given-names>
            </name>
          </person-group>
          <article-title>Genetic determinants of C-reactive protein</article-title>
          <source>Curr Atheroscler Rep</source>
          <year>2007</year>
          <volume>9</volume>
          <fpage>195</fpage>
          <lpage>203</lpage>
          <pub-id pub-id-type="pmid">18241613</pub-id>
        </citation>
      </ref>
      <ref id="bib7">
        <label>[7]</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Miller</surname>
              <given-names>D.T.</given-names>
            </name>
            <name>
              <surname>Zee</surname>
              <given-names>R.Y.</given-names>
            </name>
            <name>
              <surname>Suk Danik</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Kozlowski</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Chasman</surname>
              <given-names>D.I.</given-names>
            </name>
            <name>
              <surname>Lazarus</surname>
              <given-names>R.</given-names>
            </name>
          </person-group>
          <article-title>Association of common CRP gene variants with CRP levels and cardiovascular events</article-title>
          <source>Ann Hum Genet</source>
          <year>2005</year>
          <volume>69</volume>
          <fpage>623</fpage>
          <lpage>638</lpage>
          <pub-id pub-id-type="pmid">16266402</pub-id>
        </citation>
      </ref>
      <ref id="bib8">
        <label>[8]</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ridker</surname>
              <given-names>P.M.</given-names>
            </name>
            <name>
              <surname>Pare</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Parker</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Zee</surname>
              <given-names>R.Y.</given-names>
            </name>
            <name>
              <surname>Danik</surname>
              <given-names>J.S.</given-names>
            </name>
            <name>
              <surname>Buring</surname>
              <given-names>J.E.</given-names>
            </name>
          </person-group>
          <article-title>Loci related to metabolic-syndrome pathways including LEPR, HNF1A, IL6R, and GCKR associate with plasma C-reactive protein: The Women's Genome Health Study</article-title>
          <source>Am J Hum Genet</source>
          <year>2008</year>
          <volume>82</volume>
          <fpage>1185</fpage>
          <lpage>1192</lpage>
          <pub-id pub-id-type="pmid">18439548</pub-id>
        </citation>
      </ref>
      <ref id="bib9">
        <label>[9]</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hubacek</surname>
              <given-names>J.A.</given-names>
            </name>
            <name>
              <surname>Stavek</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Adamkova</surname>
              <given-names>V.</given-names>
            </name>
            <name>
              <surname>Lanska</surname>
              <given-names>V.</given-names>
            </name>
            <name>
              <surname>Skodova</surname>
              <given-names>Z.</given-names>
            </name>
          </person-group>
          <article-title>Apolipoprotein CI, and not apolipoprotein E, polymorphism affects plasma levels of C-reactive protein?</article-title>
          <source>Nutr Metab Cardiovasc Dis</source>
          <year>2005</year>
          <volume>15</volume>
          <fpage>450</fpage>
          <lpage>451</lpage>
          <pub-id pub-id-type="pmid">16314231</pub-id>
        </citation>
      </ref>
      <ref id="bib10">
        <label>[10]</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Davignon</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Gregg</surname>
              <given-names>R.E.</given-names>
            </name>
            <name>
              <surname>Sing</surname>
              <given-names>C.F.</given-names>
            </name>
          </person-group>
          <article-title>Apolipoprotein E polymorphism and atherosclerosis</article-title>
          <source>Arteriosclerosis</source>
          <year>1988</year>
          <volume>8</volume>
          <fpage>1</fpage>
          <lpage>21</lpage>
          <pub-id pub-id-type="pmid">3277611</pub-id>
        </citation>
      </ref>
      <ref id="bib11">
        <label>[11]</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gerdes</surname>
              <given-names>L.U.</given-names>
            </name>
            <name>
              <surname>Klausen</surname>
              <given-names>I.C.</given-names>
            </name>
            <name>
              <surname>Sihm</surname>
              <given-names>I.</given-names>
            </name>
            <name>
              <surname>Faergeman</surname>
              <given-names>O.</given-names>
            </name>
          </person-group>
          <article-title>Apolipoprotein E polymorphism in a Danish population compared to findings in 45 other study populations around the world</article-title>
          <source>Genet Epidemiol</source>
          <year>1992</year>
          <volume>9</volume>
          <fpage>155</fpage>
          <lpage>167</lpage>
          <pub-id pub-id-type="pmid">1381696</pub-id>
        </citation>
      </ref>
      <ref id="bib12">
        <label>[12]</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Svobodova</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Kucera</surname>
              <given-names>F.</given-names>
            </name>
            <name>
              <surname>Stulc</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Vrablik</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Amartuvshin</surname>
              <given-names>B.</given-names>
            </name>
            <name>
              <surname>Altannavch</surname>
              <given-names>T.</given-names>
            </name>
          </person-group>
          <article-title>Apolipoprotein E gene polymorphism in the Mongolian population</article-title>
          <source>Folia Biol (Praha)</source>
          <year>2007</year>
          <volume>53</volume>
          <fpage>138</fpage>
          <lpage>142</lpage>
          <pub-id pub-id-type="pmid">17706019</pub-id>
        </citation>
      </ref>
      <ref id="bib13">
        <label>[13]</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hubacek</surname>
              <given-names>J.A.</given-names>
            </name>
            <name>
              <surname>Pitha</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Stavek</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Schmitz</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Poledne</surname>
              <given-names>R.</given-names>
            </name>
          </person-group>
          <article-title>Variable expression of hypercholesterolemia in Apolipoprotein E2* (Arg136 &#x2013;&gt; Cys) heterozygotes</article-title>
          <source>Physiol Res</source>
          <year>2000</year>
          <volume>49</volume>
          <fpage>307</fpage>
          <lpage>314</lpage>
          <pub-id pub-id-type="pmid">11043917</pub-id>
        </citation>
      </ref>
      <ref id="bib14">
        <label>[14]</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Jofre-Monseny</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Minihane</surname>
              <given-names>A.M.</given-names>
            </name>
            <name>
              <surname>Rimbach</surname>
              <given-names>G.</given-names>
            </name>
          </person-group>
          <article-title>Impact of apoE genotype on oxidative stress, inflammation and disease risk</article-title>
          <source>Mol Nutr Food Res</source>
          <year>2008</year>
          <volume>52</volume>
          <fpage>131</fpage>
          <lpage>145</lpage>
          <pub-id pub-id-type="pmid">18203129</pub-id>
        </citation>
      </ref>
      <ref id="bib15">
        <label>[15]</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kattan</surname>
              <given-names>O.M.</given-names>
            </name>
            <name>
              <surname>Kasravi</surname>
              <given-names>F.B.</given-names>
            </name>
            <name>
              <surname>Elford</surname>
              <given-names>E.L.</given-names>
            </name>
            <name>
              <surname>Schell</surname>
              <given-names>M.T.</given-names>
            </name>
            <name>
              <surname>Harris</surname>
              <given-names>H.W.</given-names>
            </name>
          </person-group>
          <article-title>Apolipoprotein E-mediated immune regulation in sepsis</article-title>
          <source>J Immunol</source>
          <year>2008</year>
          <volume>181</volume>
          <fpage>1399</fpage>
          <lpage>1408</lpage>
          <pub-id pub-id-type="pmid">18606694</pub-id>
        </citation>
      </ref>
      <ref id="bib16">
        <label>[16]</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Moretti</surname>
              <given-names>E.W.</given-names>
            </name>
            <name>
              <surname>Morris</surname>
              <given-names>R.W.</given-names>
            </name>
            <name>
              <surname>Podgoreanu</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Schwinn</surname>
              <given-names>D.A.</given-names>
            </name>
            <name>
              <surname>Newman</surname>
              <given-names>M.F.</given-names>
            </name>
            <name>
              <surname>Bennett</surname>
              <given-names>E.</given-names>
            </name>
          </person-group>
          <article-title>APOE polymorphism is associated with risk of severe sepsis in surgical patients</article-title>
          <source>Crit Care Med</source>
          <year>2005</year>
          <volume>33</volume>
          <fpage>2521</fpage>
          <lpage>2526</lpage>
          <pub-id pub-id-type="pmid">16276176</pub-id>
        </citation>
      </ref>
      <ref id="bib17">
        <label>[17]</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Manttari</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Manninen</surname>
              <given-names>V.</given-names>
            </name>
            <name>
              <surname>Palosuo</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Ehnholm</surname>
              <given-names>C.</given-names>
            </name>
          </person-group>
          <article-title>Apolipoprotein E polymorphism and C-reactive protein in dyslipidemic middle-aged men</article-title>
          <source>Atherosclerosis</source>
          <year>2001</year>
          <volume>156</volume>
          <fpage>237</fpage>
          <lpage>238</lpage>
          <pub-id pub-id-type="pmid">11417521</pub-id>
        </citation>
      </ref>
      <ref id="bib18">
        <label>[18]</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Marz</surname>
              <given-names>W.</given-names>
            </name>
            <name>
              <surname>Scharnagl</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Hoffmann</surname>
              <given-names>M.M.</given-names>
            </name>
            <name>
              <surname>Boehm</surname>
              <given-names>B.O.</given-names>
            </name>
            <name>
              <surname>Winkelmann</surname>
              <given-names>B.R.</given-names>
            </name>
          </person-group>
          <article-title>The apolipoprotein E polymorphism is associated with circulating C-reactive protein (the Ludwigshafen risk and cardiovascular health study)</article-title>
          <source>Eur Heart J</source>
          <year>2004</year>
          <volume>25</volume>
          <fpage>2109</fpage>
          <lpage>2119</lpage>
          <pub-id pub-id-type="pmid">15571826</pub-id>
        </citation>
      </ref>
      <ref id="bib19">
        <label>[19]</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rontu</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Ojala</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Hervonen</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Goebeler</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Karhunen</surname>
              <given-names>P.J.</given-names>
            </name>
            <name>
              <surname>Nikkila</surname>
              <given-names>M.</given-names>
            </name>
          </person-group>
          <article-title>Apolipoprotein E genotype is related to plasma levels of C-reactive protein and lipids and to longevity in nonagenarians</article-title>
          <source>Clin Endocrinol (Oxf)</source>
          <year>2006</year>
          <volume>64</volume>
          <fpage>265</fpage>
          <lpage>270</lpage>
          <pub-id pub-id-type="pmid">16487435</pub-id>
        </citation>
      </ref>
      <ref id="bib20">
        <label>[20]</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lange</surname>
              <given-names>L.A.</given-names>
            </name>
            <name>
              <surname>Burdon</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Langefeld</surname>
              <given-names>C.D.</given-names>
            </name>
            <name>
              <surname>Liu</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Beck</surname>
              <given-names>S.R.</given-names>
            </name>
            <name>
              <surname>Rich</surname>
              <given-names>S.S.</given-names>
            </name>
          </person-group>
          <article-title>Heritability and expression of C-reactive protein in type 2 diabetes in the Diabetes Heart Study</article-title>
          <source>Ann Hum Genet</source>
          <year>2006</year>
          <volume>70</volume>
          <fpage>717</fpage>
          <lpage>725</lpage>
          <pub-id pub-id-type="pmid">17044846</pub-id>
        </citation>
      </ref>
      <ref id="bib21">
        <label>[21]</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Eiriksdottir</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Aspelund</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Bjarnadottir</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Olafsdottir</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Gudnason</surname>
              <given-names>V.</given-names>
            </name>
            <name>
              <surname>Launer</surname>
              <given-names>L.J.</given-names>
            </name>
          </person-group>
          <article-title>Apolipoprotein E genotype and statins affect CRP levels through independent and different mechanisms: AGES-Reykjavik Study</article-title>
          <source>Atherosclerosis</source>
          <year>2006</year>
          <volume>186</volume>
          <fpage>222</fpage>
          <lpage>224</lpage>
          <pub-id pub-id-type="pmid">16445917</pub-id>
        </citation>
      </ref>
      <ref id="bib22">
        <label>[22]</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Mooijaart</surname>
              <given-names>S.P.</given-names>
            </name>
            <name>
              <surname>Berbee</surname>
              <given-names>J.F.</given-names>
            </name>
            <name>
              <surname>van Heemst</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Havekes</surname>
              <given-names>L.M.</given-names>
            </name>
            <name>
              <surname>de Craen</surname>
              <given-names>A.J.</given-names>
            </name>
            <name>
              <surname>Slagboom</surname>
              <given-names>P.E.</given-names>
            </name>
          </person-group>
          <article-title>ApoE plasma levels and risk of cardiovascular mortality in old age</article-title>
          <source>PLoS Med</source>
          <year>2006</year>
          <volume>3</volume>
          <fpage>e176</fpage>
          <pub-id pub-id-type="pmid">16671834</pub-id>
        </citation>
      </ref>
      <ref id="bib23">
        <label>[23]</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gronroos</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Raitakari</surname>
              <given-names>O.T.</given-names>
            </name>
            <name>
              <surname>Kahonen</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Hutri-Kahonen</surname>
              <given-names>N.</given-names>
            </name>
            <name>
              <surname>Marniemi</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Viikari</surname>
              <given-names>J.</given-names>
            </name>
          </person-group>
          <article-title>Association of high sensitive C-reactive protein with apolipoprotein E polymorphism in children and young adults: The cardiovascular risk in Young Finns study</article-title>
          <source>Clin Chem Lab Med</source>
          <year>2008</year>
          <volume>46</volume>
          <fpage>179</fpage>
          <lpage>186</lpage>
          <pub-id pub-id-type="pmid">18324906</pub-id>
        </citation>
      </ref>
      <ref id="bib24">
        <label>[24]</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Berrahmoune</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Herbeth</surname>
              <given-names>B.</given-names>
            </name>
            <name>
              <surname>Siest</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Visvikis-Siest</surname>
              <given-names>S.</given-names>
            </name>
          </person-group>
          <article-title>Heritability of serum hs-CRP concentration and 5-year changes in the Stanislas family study: Association with apolipoprotein E alleles</article-title>
          <source>Genes Immun</source>
          <year>2007</year>
          <volume>8</volume>
          <fpage>352</fpage>
          <lpage>359</lpage>
          <pub-id pub-id-type="pmid">17460724</pub-id>
        </citation>
      </ref>
      <ref id="bib25">
        <label>[25]</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Chasman</surname>
              <given-names>D.I.</given-names>
            </name>
            <name>
              <surname>Kozlowski</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Zee</surname>
              <given-names>R.Y.</given-names>
            </name>
            <name>
              <surname>Kwiatkowski</surname>
              <given-names>D.J.</given-names>
            </name>
            <name>
              <surname>Ridker</surname>
              <given-names>P.M.</given-names>
            </name>
          </person-group>
          <article-title>Qualitative and quantitative effects of APOE genetic variation on plasma C-reactive protein, LDL-cholesterol, and apoE protein</article-title>
          <source>Genes Immun</source>
          <year>2006</year>
          <volume>7</volume>
          <fpage>211</fpage>
          <lpage>219</lpage>
          <pub-id pub-id-type="pmid">16511556</pub-id>
        </citation>
      </ref>
      <ref id="bib26">
        <label>[26]</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kahri</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Soro-Paavonen</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Ehnholm</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Taskinen</surname>
              <given-names>M.R.</given-names>
            </name>
          </person-group>
          <article-title>ApoE polymorphism is associated with C-reactive protein in low-HDL family members and in normolipidemic subjects</article-title>
          <source>Mediators Inflamm</source>
          <year>2006</year>
          <volume>2006</volume>
          <fpage>12587</fpage>
          <pub-id pub-id-type="pmid">16951484</pub-id>
        </citation>
      </ref>
      <ref id="bib27">
        <label>[27]</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Judson</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Brain</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Dain</surname>
              <given-names>B.</given-names>
            </name>
            <name>
              <surname>Windemuth</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Ruano</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Reed</surname>
              <given-names>C.</given-names>
            </name>
          </person-group>
          <article-title>New and confirmatory evidence of an association between APOE genotype and baseline C-reactive protein in dyslipidemic individuals</article-title>
          <source>Atherosclerosis</source>
          <year>2004</year>
          <volume>177</volume>
          <fpage>345</fpage>
          <lpage>351</lpage>
          <pub-id pub-id-type="pmid">15530909</pub-id>
        </citation>
      </ref>
      <ref id="bib28">
        <label>[28]</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Paschos</surname>
              <given-names>G.K.</given-names>
            </name>
            <name>
              <surname>Yiannakouris</surname>
              <given-names>N.</given-names>
            </name>
            <name>
              <surname>Rallidis</surname>
              <given-names>L.S.</given-names>
            </name>
            <name>
              <surname>Davies</surname>
              <given-names>I.</given-names>
            </name>
            <name>
              <surname>Griffin</surname>
              <given-names>B.A.</given-names>
            </name>
            <name>
              <surname>Panagiotakos</surname>
              <given-names>D.B.</given-names>
            </name>
          </person-group>
          <article-title>Apolipoprotein E genotype in dyslipidemic patients and response of blood lipids and inflammatory markers to alpha-linolenic acid</article-title>
          <source>Angiology</source>
          <year>2005</year>
          <volume>56</volume>
          <fpage>49</fpage>
          <lpage>60</lpage>
          <pub-id pub-id-type="pmid">15678256</pub-id>
        </citation>
      </ref>
      <ref id="bib29">
        <label>[29]</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tziakas</surname>
              <given-names>D.N.</given-names>
            </name>
            <name>
              <surname>Chalikias</surname>
              <given-names>G.K.</given-names>
            </name>
            <name>
              <surname>Antonoglou</surname>
              <given-names>C.O.</given-names>
            </name>
            <name>
              <surname>Veletza</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Tentes</surname>
              <given-names>I.K.</given-names>
            </name>
            <name>
              <surname>Kortsaris</surname>
              <given-names>A.X.</given-names>
            </name>
          </person-group>
          <article-title>Apolipoprotein E genotype and circulating interleukin-10 levels in patients with stable and unstable coronary artery disease</article-title>
          <source>J Am Coll Cardiol</source>
          <year>2006</year>
          <volume>48</volume>
          <fpage>2471</fpage>
          <lpage>2481</lpage>
          <pub-id pub-id-type="pmid">17174184</pub-id>
        </citation>
      </ref>
      <ref id="bib30">
        <label>[30]</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ravaglia</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Forti</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Maioli</surname>
              <given-names>F.</given-names>
            </name>
            <name>
              <surname>Chiappelli</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Montesi</surname>
              <given-names>F.</given-names>
            </name>
            <name>
              <surname>Bianchin</surname>
              <given-names>M.</given-names>
            </name>
          </person-group>
          <article-title>Apolipoprotein E e4 allele affects risk of hyperhomocysteinemia in the elderly</article-title>
          <source>Am J Clin Nutr</source>
          <year>2006</year>
          <volume>84</volume>
          <fpage>1473</fpage>
          <lpage>1480</lpage>
          <pub-id pub-id-type="pmid">17158432</pub-id>
        </citation>
      </ref>
      <ref id="bib31">
        <label>[31]</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Haan</surname>
              <given-names>M.N.</given-names>
            </name>
            <name>
              <surname>Aiello</surname>
              <given-names>A.E.</given-names>
            </name>
            <name>
              <surname>West</surname>
              <given-names>N.A.</given-names>
            </name>
            <name>
              <surname>Jagust</surname>
              <given-names>W.J.</given-names>
            </name>
          </person-group>
          <article-title>C-reactive protein and rate of dementia in carriers and non carriers of apolipoprotein APOE4 genotype</article-title>
          <source>Neurobiol Aging</source>
          <year>2008</year>
          <volume>29</volume>
          <fpage>1774</fpage>
          <lpage>1782</lpage>
          <pub-id pub-id-type="pmid">17540481</pub-id>
        </citation>
      </ref>
      <ref id="bib32">
        <label>[32]</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Angelopoulos</surname>
              <given-names>T.J.</given-names>
            </name>
            <name>
              <surname>Miles</surname>
              <given-names>M.P.</given-names>
            </name>
            <name>
              <surname>Lowndes</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Sivo</surname>
              <given-names>S.A.</given-names>
            </name>
            <name>
              <surname>Seip</surname>
              <given-names>R.L.</given-names>
            </name>
            <name>
              <surname>Pescatello</surname>
              <given-names>L.S.</given-names>
            </name>
          </person-group>
          <article-title>Apolipoprotein E genotype and sex influence C-reactive protein levels regardless of exercise training status</article-title>
          <source>Metabolism</source>
          <year>2008</year>
          <volume>57</volume>
          <fpage>1204</fpage>
          <lpage>1210</lpage>
          <pub-id pub-id-type="pmid">18702945</pub-id>
        </citation>
      </ref>
      <ref id="bib33">
        <label>[33]</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kravitz</surname>
              <given-names>B.A.</given-names>
            </name>
            <name>
              <surname>Corrada</surname>
              <given-names>M.M.</given-names>
            </name>
            <name>
              <surname>Kawas</surname>
              <given-names>C.H.</given-names>
            </name>
          </person-group>
          <article-title>High levels of serum C-reactive protein are associated with greater risk of all-cause mortality, but not dementia, in the oldest-old: Results from the 90+ study</article-title>
          <source>J Am Geriatr Soc</source>
          <year>2009</year>
          <volume>57</volume>
          <fpage>641</fpage>
          <lpage>646</lpage>
          <pub-id pub-id-type="pmid">19245412</pub-id>
        </citation>
      </ref>
      <ref id="bib34">
        <label>[34]</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Park</surname>
              <given-names>S.Y.</given-names>
            </name>
            <name>
              <surname>Kim</surname>
              <given-names>M.H.</given-names>
            </name>
            <name>
              <surname>Kang</surname>
              <given-names>S.Y.</given-names>
            </name>
            <name>
              <surname>Suh</surname>
              <given-names>J.T.</given-names>
            </name>
            <name>
              <surname>Lee</surname>
              <given-names>W.I.</given-names>
            </name>
          </person-group>
          <article-title>Inflammatory marker expression and its implication in Korean ischemic stroke patients</article-title>
          <source>Korean J Lab Med</source>
          <year>2007</year>
          <volume>27</volume>
          <fpage>197</fpage>
          <lpage>204</lpage>
          <pub-id pub-id-type="pmid">18094576</pub-id>
        </citation>
      </ref>
      <ref id="bib35">
        <label>[35]</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Austin</surname>
              <given-names>M.A.</given-names>
            </name>
            <name>
              <surname>Zhang</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Humphries</surname>
              <given-names>S.E.</given-names>
            </name>
            <name>
              <surname>Chandler</surname>
              <given-names>W.L.</given-names>
            </name>
            <name>
              <surname>Talmud</surname>
              <given-names>P.J.</given-names>
            </name>
            <name>
              <surname>Edwards</surname>
              <given-names>K.L.</given-names>
            </name>
          </person-group>
          <article-title>Heritability of C-reactive protein and association with apolipoprotein E genotypes in Japanese Americans</article-title>
          <source>Ann Hum Genet</source>
          <year>2004</year>
          <volume>68</volume>
          <fpage>179</fpage>
          <lpage>188</lpage>
          <pub-id pub-id-type="pmid">15180698</pub-id>
        </citation>
      </ref>
      <ref id="bib36">
        <label>[36]</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Mahley</surname>
              <given-names>R.W.</given-names>
            </name>
          </person-group>
          <article-title>Apolipoprotein E: Cholesterol transport protein with expanding role in cell biology</article-title>
          <source>Science</source>
          <year>1988</year>
          <volume>240</volume>
          <fpage>622</fpage>
          <lpage>630</lpage>
          <pub-id pub-id-type="pmid">3283935</pub-id>
        </citation>
      </ref>
      <ref id="bib37">
        <label>[37]</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Peasey</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Bobak</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Kubinova</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Malyutina</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Pajak</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Tamosiunas</surname>
              <given-names>A.</given-names>
            </name>
          </person-group>
          <article-title>Determinants of cardiovascular disease and other non-communicable diseases in Central and Eastern Europe: Rationale and design of the HAPIEE study</article-title>
          <source>BMC Public Health</source>
          <year>2006</year>
          <volume>6</volume>
          <fpage>255</fpage>
          <pub-id pub-id-type="pmid">17049075</pub-id>
        </citation>
      </ref>
      <ref id="bib38">
        <label>[38]</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Miller</surname>
              <given-names>S.A.</given-names>
            </name>
            <name>
              <surname>Dykes</surname>
              <given-names>D.D.</given-names>
            </name>
            <name>
              <surname>Polesky</surname>
              <given-names>H.F.</given-names>
            </name>
          </person-group>
          <article-title>A simple salting out procedure for extracting DNA from human nucleated cells</article-title>
          <source>Nucleic Acids Res</source>
          <year>1988</year>
          <volume>16</volume>
          <fpage>1215</fpage>
          <pub-id pub-id-type="pmid">3344216</pub-id>
        </citation>
      </ref>
      <ref id="bib39">
        <label>[39]</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hixson</surname>
              <given-names>J.E.</given-names>
            </name>
            <name>
              <surname>Vernier</surname>
              <given-names>D.T.</given-names>
            </name>
          </person-group>
          <article-title>Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI</article-title>
          <source>J Lipid Res</source>
          <year>1990</year>
          <volume>31</volume>
          <fpage>545</fpage>
          <lpage>548</lpage>
          <pub-id pub-id-type="pmid">2341813</pub-id>
        </citation>
      </ref>
      <ref id="bib40">
        <label>[40]</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hubacek</surname>
              <given-names>J.A.</given-names>
            </name>
            <name>
              <surname>Adamkova</surname>
              <given-names>V.</given-names>
            </name>
            <name>
              <surname>Stavek</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Kubinova</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Peasey</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Pikhart</surname>
              <given-names>H.</given-names>
            </name>
          </person-group>
          <article-title>Apolipoprotein E Arg136 &#x2013;&gt; Cys mutation and hyperlipidemia in a large central European population sample</article-title>
          <source>Clin Chim Acta</source>
          <year>2008</year>
          <volume>388</volume>
          <fpage>217</fpage>
          <lpage>218</lpage>
          <pub-id pub-id-type="pmid">18326082</pub-id>
        </citation>
      </ref>
      <ref id="bib41">
        <label>[41]</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Westhuyzen</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Healy</surname>
              <given-names>H.</given-names>
            </name>
          </person-group>
          <article-title>Review: Biology and relevance of C-reactive protein in cardiovascular and renal disease</article-title>
          <source>Ann Clin Lab Sci</source>
          <year>2000</year>
          <volume>30</volume>
          <fpage>133</fpage>
          <lpage>143</lpage>
          <pub-id pub-id-type="pmid">10807156</pub-id>
        </citation>
      </ref>
      <ref id="bib42">
        <label>[42]</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bach-Ngohou</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Nazih</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Nazih-Sanderson</surname>
              <given-names>F.</given-names>
            </name>
            <name>
              <surname>Zair</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Le Carrer</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Krempf</surname>
              <given-names>M.</given-names>
            </name>
          </person-group>
          <article-title>Negative and independent influence of apolipoprotein E on C-reactive protein (CRP) concentration in obese adults</article-title>
          <source>Int J Obes Relat Metab Disord</source>
          <year>2001</year>
          <volume>25</volume>
          <fpage>1752</fpage>
          <lpage>1758</lpage>
          <pub-id pub-id-type="pmid">11781754</pub-id>
        </citation>
      </ref>
      <ref id="bib43">
        <label>[43]</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Utermann</surname>
              <given-names>G.</given-names>
            </name>
          </person-group>
          <article-title>Apolipoprotein E mutants, hyperlipidemia and arteriosclerosis</article-title>
          <source>Adv Exp Med Biol</source>
          <year>1985</year>
          <volume>183</volume>
          <fpage>173</fpage>
          <lpage>188</lpage>
          <pub-id pub-id-type="pmid">4036699</pub-id>
        </citation>
      </ref>
      <ref id="bib44">
        <label>[44]</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zacho</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Tybjaerg-Hansen</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Jensen</surname>
              <given-names>J.S.</given-names>
            </name>
            <name>
              <surname>Grande</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Sillesen</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Nordestgaard</surname>
              <given-names>B.G.</given-names>
            </name>
          </person-group>
          <article-title>Genetically elevated C-reactive protein and ischemic vascular disease</article-title>
          <source>N Engl J Med</source>
          <year>2008</year>
          <volume>359</volume>
          <fpage>1897</fpage>
          <lpage>1908</lpage>
          <pub-id pub-id-type="pmid">18971492</pub-id>
        </citation>
      </ref>
    </ref-list>
  </back>
  <floats-wrap>
    <table-wrap position="float" id="tbl1">
      <label>Table 1</label>
      <caption>
        <p>Previous population-based studies on <italic>APOE</italic> genotype and CRP levels</p>
      </caption>
      <table frame="hsides" rules="groups">
        <thead>
          <tr>
            <th align="left">Main author</th>
            <th align="left">Year</th>
            <th align="left">Study population</th>
            <th align="left">Measure of CRP levels</th>
            <th align="left">Number of persons</th>
            <th align="left">Main findings</th>
            <th align="left">Differences in CRP statistically significant?</th>
          </tr>
        </thead>
        <tbody>
          <tr>
            <td align="left">Kravitz et al. <xref rid="bib33" ref-type="bibr">[33]</xref></td>
            <td align="center">2009</td>
            <td align="left">Persons aged 90+</td>
            <td align="left">3 groups</td>
            <td align="right">227</td>
            <td align="left">No association</td>
            <td align="left">No</td>
          </tr>
          <tr>
            <td align="left">Angelopoulos et al. <xref rid="bib32" ref-type="bibr">[32]</xref></td>
            <td align="center">2008</td>
            <td align="left">Healthy volunteers</td>
            <td align="left">Geometric mean</td>
            <td align="right">117</td>
            <td align="left">Lower CRP in &#x3B5;3/ &#x3B5;4</td>
            <td align="left">Marginally</td>
          </tr>
          <tr>
            <td align="left">Haan et al. <xref rid="bib31" ref-type="bibr">[31]</xref></td>
            <td align="center">2008</td>
            <td align="left">Elderly Latinos</td>
            <td align="left">Median</td>
            <td align="right">1445</td>
            <td align="left">Lower CRP in &#x3B5;3/ &#x3B5;4</td>
            <td align="left">Yes</td>
          </tr>
          <tr>
            <td align="left">Gronroos et al. <xref rid="bib23" ref-type="bibr">[23]</xref></td>
            <td align="center">2008</td>
            <td align="left">General young population</td>
            <td align="left">Geometric mean</td>
            <td align="right">1221</td>
            <td align="left">Lower in &#x3B5;4 in men, not in females</td>
            <td align="left">Yes/No</td>
          </tr>
          <tr>
            <td align="left">Berrahmoune et al. <xref rid="bib24" ref-type="bibr">[24]</xref></td>
            <td align="center">2007</td>
            <td align="left">General population</td>
            <td align="left">Geometric mean</td>
            <td align="right">1223</td>
            <td align="left">Lower CRP in &#x3B5;4</td>
            <td align="left">Yes</td>
          </tr>
          <tr>
            <td align="left">Park et al. <xref rid="bib34" ref-type="bibr">[34]</xref></td>
            <td align="center">2007</td>
            <td align="left">Healthy controls</td>
            <td align="left">Arithmetic mean</td>
            <td align="right">119</td>
            <td align="left">No association</td>
            <td align="left">No</td>
          </tr>
          <tr>
            <td align="left">Kahri et al. <xref rid="bib26" ref-type="bibr">[26]</xref></td>
            <td align="center">2006</td>
            <td align="left">Low HDL &amp; normo-lipidaemic subjects</td>
            <td align="left">Geometric mean</td>
            <td align="right">368</td>
            <td align="left">CRP lower in &#x3B5;4</td>
            <td align="left">Yes</td>
          </tr>
          <tr>
            <td align="left">Tziakas et al. <xref rid="bib29" ref-type="bibr">[29]</xref></td>
            <td align="center">2006</td>
            <td align="left">Patients with angina &amp; acute coronary syndrome</td>
            <td align="left">Non-parametric</td>
            <td align="right">166</td>
            <td align="left">CRP lower in &#x3B5;4</td>
            <td align="left">Yes</td>
          </tr>
          <tr>
            <td align="left">Ravaglia et al. <xref rid="bib30" ref-type="bibr">[30]</xref></td>
            <td align="center">2006</td>
            <td align="left">General 65+</td>
            <td align="left">Binary</td>
            <td align="right">671</td>
            <td align="left">CRP lower in &#x3B5;4</td>
            <td align="left">No</td>
          </tr>
          <tr>
            <td align="left">Lange et al. <xref rid="bib20" ref-type="bibr">[20]</xref></td>
            <td align="center">2006</td>
            <td align="left">Diabetics</td>
            <td align="left">Geometric mean</td>
            <td align="right">241</td>
            <td align="left">CRP lower in &#x3B5;4</td>
            <td align="left">Marginally</td>
          </tr>
          <tr>
            <td align="left">Mooijaart et al. <xref rid="bib22" ref-type="bibr">[22]</xref></td>
            <td align="center">2006</td>
            <td align="left">Persons aged 85+</td>
            <td align="left">Geometric mean</td>
            <td align="right">594</td>
            <td align="left">CRP lower in &#x3B5;4</td>
            <td align="left">Yes</td>
          </tr>
          <tr>
            <td align="left">Chasman et al. <xref rid="bib25" ref-type="bibr">[25]</xref></td>
            <td align="center">2006</td>
            <td align="left">General population</td>
            <td align="left">Geometric mean</td>
            <td align="right">2053</td>
            <td align="left">CRP lower in &#x3B5;4</td>
            <td align="left">Yes</td>
          </tr>
          <tr>
            <td align="left">Rontu et al. <xref rid="bib19" ref-type="bibr">[19]</xref></td>
            <td align="center">2006</td>
            <td align="left">90+</td>
            <td align="left">Geometric mean</td>
            <td align="right">291</td>
            <td align="left">CRP lower in &#x3B5;4</td>
            <td align="left">Yes</td>
          </tr>
          <tr>
            <td align="left">Eiriksdotrir et al. <xref rid="bib21" ref-type="bibr">[21]</xref></td>
            <td align="center">2006</td>
            <td align="left">Older general population</td>
            <td align="left">Geometric mean</td>
            <td align="right">2251</td>
            <td align="left">CRP lower in &#x3B5;4</td>
            <td align="left">Yes</td>
          </tr>
          <tr>
            <td align="left">Paschos et al. <xref rid="bib28" ref-type="bibr">[28]</xref></td>
            <td align="center">2005</td>
            <td align="left">Dyslipidaemic</td>
            <td align="left">Median</td>
            <td align="right">50</td>
            <td align="left">CRP lower in &#x3B5;4</td>
            <td align="left">No</td>
          </tr>
          <tr>
            <td align="left">Judson et al. <xref rid="bib27" ref-type="bibr">[27]</xref></td>
            <td align="center">2004</td>
            <td align="left">Dislipidaemic</td>
            <td align="left">Geometric mean</td>
            <td align="right">600</td>
            <td align="left">CRP lower in &#x3B5;4</td>
            <td align="left">yes</td>
          </tr>
          <tr>
            <td align="left">Marz et al. <xref rid="bib18" ref-type="bibr">[18]</xref></td>
            <td align="center">2004</td>
            <td align="left">Patients with CHD and healthy controls</td>
            <td align="left">Geometric mean</td>
            <td align="right">1309</td>
            <td align="left">CRP lower in &#x3B5;4</td>
            <td align="left">Yes</td>
          </tr>
          <tr>
            <td align="left">Austin et al. <xref rid="bib35" ref-type="bibr">[35]</xref></td>
            <td align="center">2004</td>
            <td align="left">Japanese Americans from 68 kindreds</td>
            <td align="left">Geometric mean</td>
            <td align="right">558</td>
            <td align="left">CRP similar in &#x3B5;4 and &#x3B5;3/ &#x3B5;3 but lower than in &#x3B5;2</td>
            <td align="left">Marginally</td>
          </tr>
          <tr>
            <td align="left">Manttari et al. <xref rid="bib17" ref-type="bibr">[17]</xref></td>
            <td align="center">2001</td>
            <td align="left">Cases of MI and controls</td>
            <td align="left">Arithmetic mean</td>
            <td align="right">177</td>
            <td align="left">CRP lower in &#x3B5;4</td>
            <td align="left">Yes</td>
          </tr>
        </tbody>
      </table>
      <table-wrap-foot>
        <fn>
          <p>Note: Studies were identified in PubMed using the following combinations of search terms: (&#x201C;apoe&#x201D; or &#x201C;apo e&#x201D; or &#x201C;apoliporotein e&#x201D;) and (&#x201C;genotype&#x201D; or &#x201C;gene&#x201D; or &#x201C;polymorphisms&#x201D;) and (&#x201C;crp&#x201D; or &#x201C;c-reactive protein&#x201D;).</p>
        </fn>
      </table-wrap-foot>
    </table-wrap>
    <table-wrap position="float" id="tbl2">
      <label>Table 2</label>
      <caption>
        <p>Basic characteristics of subjects included in the analysis</p>
      </caption>
      <table frame="hsides" rules="groups">
        <thead>
          <tr>
            <th align="left"/>
            <th align="left">Men</th>
            <th align="left">Women</th>
          </tr>
        </thead>
        <tbody>
          <tr>
            <td align="left">N</td>
            <td align="center">2886</td>
            <td align="center">3344</td>
          </tr>
          <tr>
            <td align="left">Age, mean (SD), yr</td>
            <td align="center">58.2&#xA0;(7.2)</td>
            <td align="center">57.4&#xA0;(7.2)</td>
          </tr>
          <tr>
            <td align="left">Total cholesterol, mean (SD), mmol/l</td>
            <td align="center">5.62&#xA0;(1.04)</td>
            <td align="center">5.82&#xA0;(1.04)</td>
          </tr>
          <tr>
            <td align="left">BMI, mean (SD), kg/m<sup>2</sup></td>
            <td align="center">28.2&#xA0;(3.9)</td>
            <td align="center">27.9&#xA0;(4.9)</td>
          </tr>
          <tr>
            <td align="left">Hypertension, %</td>
            <td align="center">72.5%</td>
            <td align="center">57.9%</td>
          </tr>
          <tr>
            <td align="left">Current smoking prevalence, %</td>
            <td align="center">25.9%</td>
            <td align="center">20.3%</td>
          </tr>
          <tr>
            <td align="left">History of myocardial infarction, %</td>
            <td align="center">7.8%</td>
            <td align="center">2.4%</td>
          </tr>
          <tr>
            <td align="left">History of angina, %</td>
            <td align="center">5.1%</td>
            <td align="center">3.3%</td>
          </tr>
          <tr>
            <td align="left">History of stroke, %</td>
            <td align="center">3.5%</td>
            <td align="center">2.5%</td>
          </tr>
          <tr>
            <td align="left">CRP, median (IQR), mg/l</td>
            <td align="center">1.08&#xA0;(0.56,&#xA0;2.19)</td>
            <td align="center">1.19&#xA0;(0.57,&#xA0;2.61)</td>
          </tr>
        </tbody>
      </table>
    </table-wrap>
    <table-wrap position="float" id="tbl3">
      <label>Table 3</label>
      <caption>
        <p>Median (IQR) concentrations of CRP by <italic>APOE</italic> genotype and odds ratios (95% confidence intervals) from ordered logistic regression (with quartiles of CRP as dependent variable), by sex</p>
      </caption>
      <table frame="hsides" rules="groups">
        <thead>
          <tr>
            <th align="left">
              <italic>APOE</italic>
            </th>
            <th align="left">N</th>
            <th align="left">%</th>
            <th align="left">Median (IQR) of CRP concentrations (mg/l)</th>
            <th align="left">Odds ratio (95% CI)</th>
          </tr>
        </thead>
        <tbody>
          <tr>
            <td align="left">Men</td>
            <td/>
            <td/>
            <td/>
            <td/>
          </tr>
          <tr>
            <td align="left">&#xA0;All</td>
            <td align="right">2886</td>
            <td align="right">100</td>
            <td align="char">1.08&#xA0;(0.56,&#xA0;2.19)</td>
            <td align="left">&#x2014;</td>
          </tr>
          <tr>
            <td align="left">&#xA0;22</td>
            <td align="right">15</td>
            <td align="right">0.5</td>
            <td align="char">0.82&#xA0;(0.45,&#xA0;2.83)</td>
            <td align="char">0.76&#xA0;(0.29&#x2013;1.97)</td>
          </tr>
          <tr>
            <td align="left">&#xA0;32</td>
            <td align="right">309</td>
            <td align="right">10.7</td>
            <td align="char">1.12&#xA0;(0.57,&#xA0;2.16)</td>
            <td align="char">0.97&#xA0;(0.78&#x2013;1.20)</td>
          </tr>
          <tr>
            <td align="left">&#xA0;33</td>
            <td align="right">1926</td>
            <td align="right">66.7</td>
            <td align="char">1.13&#xA0;(0.56,&#xA0;2.33)</td>
            <td align="char">1.0&#xA0;(reference)</td>
          </tr>
          <tr>
            <td align="left">&#xA0;42</td>
            <td align="right">56</td>
            <td align="right">1.9</td>
            <td align="char">1.10&#xA0;(0.60,&#xA0;2.01)</td>
            <td align="char">0.93&#xA0;(0.58&#x2013;1.47)</td>
          </tr>
          <tr>
            <td align="left">&#xA0;43</td>
            <td align="right">551</td>
            <td align="right">19.1</td>
            <td align="char">0.91&#xA0;(0.52,&#xA0;1.91)</td>
            <td align="char">0.77&#xA0;(0.65&#x2013;0.92)</td>
          </tr>
          <tr>
            <td align="left">&#xA0;44</td>
            <td align="right">29</td>
            <td align="right">1.0</td>
            <td align="char">0.61&#xA0;(0.35,&#xA0;1.19)</td>
            <td align="char">0.34&#xA0;(0.17&#x2013;0.68)</td>
          </tr>
          <tr>
            <td/>
            <td/>
            <td/>
            <td align="left"><italic>p =</italic> 0.0004<xref rid="tblfn1" ref-type="table-fn">a</xref></td>
            <td/>
          </tr>
          <tr>
            <td align="left">&#xA0;33</td>
            <td align="right">1926</td>
            <td align="right">66.7</td>
            <td align="char">1.13&#xA0;(0.56,&#xA0;2.33)</td>
            <td align="char">1.0&#xA0;(reference)</td>
          </tr>
          <tr>
            <td align="left">&#xA0;22&#xA0;+&#xA0;32</td>
            <td align="right">324</td>
            <td align="right">11.2</td>
            <td align="char">1.12&#xA0;(0.56,&#xA0;2.17)</td>
            <td align="char">0.96&#xA0;(0.78&#x2013;1.18)</td>
          </tr>
          <tr>
            <td align="left">&#xA0;43&#xA0;+&#xA0;44</td>
            <td align="right">580</td>
            <td align="right">20.1</td>
            <td align="char">0.90&#xA0;(0.49,&#xA0;1.88)</td>
            <td align="char">0.75&#xA0;(0.63&#x2013;0.88)</td>
          </tr>
          <tr>
            <td align="left">&#xA0;42</td>
            <td align="right">56</td>
            <td align="right">1.9</td>
            <td align="char">1.10&#xA0;(0.60,&#xA0;2.01)</td>
            <td align="char">0.93&#xA0;(0.58&#x2013;1.47)</td>
          </tr>
          <tr>
            <td/>
            <td/>
            <td/>
            <td align="left"><italic>p =</italic> 0.0004<xref rid="tblfn1" ref-type="table-fn">a</xref></td>
            <td/>
          </tr>
          <tr>
            <td align="left">Women</td>
            <td/>
            <td/>
            <td/>
            <td/>
          </tr>
          <tr>
            <td align="left">&#xA0;All</td>
            <td align="right">3344</td>
            <td align="right">100</td>
            <td align="char">1.19&#xA0;(0.57,&#xA0;2.61)</td>
            <td align="left">&#x2014;</td>
          </tr>
          <tr>
            <td align="left">&#xA0;22</td>
            <td align="right">27</td>
            <td align="right">0.8</td>
            <td align="char">0.81&#xA0;(0.52,&#xA0;2.33)</td>
            <td align="char">0.66&#xA0;(0.33&#x2013;1.33)</td>
          </tr>
          <tr>
            <td align="left">&#xA0;32</td>
            <td align="right">399</td>
            <td align="right">11.9</td>
            <td align="char">1.07&#xA0;(0.62,&#xA0;2.42)</td>
            <td align="char">0.88&#xA0;(0.73&#x2013;1.06)</td>
          </tr>
          <tr>
            <td align="left">&#xA0;33</td>
            <td align="right">2200</td>
            <td align="right">65.8</td>
            <td align="char">1.25&#xA0;(0.61,&#xA0;2.65)</td>
            <td align="char">1.0&#xA0;(reference)</td>
          </tr>
          <tr>
            <td align="left">&#xA0;42</td>
            <td align="right">66</td>
            <td align="right">2.0</td>
            <td align="char">1.33&#xA0;(0.58,&#xA0;3.46)</td>
            <td align="char">1.15&#xA0;(0.74&#x2013;1.79)</td>
          </tr>
          <tr>
            <td align="left">&#xA0;43</td>
            <td align="right">604</td>
            <td align="right">18.1</td>
            <td align="char">0.98&#xA0;(0.48,&#xA0;2.38)</td>
            <td align="char">0.70&#xA0;(0.60&#x2013;0.81)</td>
          </tr>
          <tr>
            <td align="left">&#xA0;44</td>
            <td align="right">48</td>
            <td align="right">1.4</td>
            <td align="char">0.91&#xA0;(0.49,&#xA0;2.64)</td>
            <td align="char">0.62&#xA0;(0.36&#x2013;1.08)</td>
          </tr>
          <tr>
            <td/>
            <td/>
            <td/>
            <td align="left"><italic>p =</italic> 0.0052<xref rid="tblfn1" ref-type="table-fn">a</xref></td>
            <td/>
          </tr>
          <tr>
            <td align="left">&#xA0;33</td>
            <td align="right">2200</td>
            <td align="right">65.8</td>
            <td align="char">1.25&#xA0;(0.61,&#xA0;2.65)</td>
            <td align="char">1.0&#xA0;(reference)</td>
          </tr>
          <tr>
            <td align="left">&#xA0;22&#xA0;+&#xA0;32</td>
            <td align="right">426</td>
            <td align="right">12.7</td>
            <td align="char">1.07&#xA0;(0.61,&#xA0;2.40)</td>
            <td align="char">0.86&#xA0;(0.72&#x2013;1.03)</td>
          </tr>
          <tr>
            <td align="left">&#xA0;43&#xA0;+&#xA0;44</td>
            <td align="right">652</td>
            <td align="right">19.5</td>
            <td align="char">0.97&#xA0;(0.48,&#xA0;2.40)</td>
            <td align="char">0.70&#xA0;(0.60&#x2013;0.83)</td>
          </tr>
          <tr>
            <td align="left">&#xA0;42</td>
            <td align="right">66</td>
            <td align="right">2.0</td>
            <td align="char">1.33&#xA0;(0.58,&#xA0;3.46)</td>
            <td align="char">1.15&#xA0;(0.74&#x2013;1.79)</td>
          </tr>
          <tr>
            <td/>
            <td/>
            <td/>
            <td align="left"><italic>p =</italic> 0.0010<xref rid="tblfn1" ref-type="table-fn">a</xref></td>
            <td/>
          </tr>
        </tbody>
      </table>
      <table-wrap-foot>
        <fn id="tblfn1">
          <label>a</label>
          <p>Kruskal-Wallis non-parametric test.</p>
        </fn>
      </table-wrap-foot>
    </table-wrap>
    <table-wrap position="float" id="tbl4">
      <label>Table 4</label>
      <caption>
        <p>Crude and adjusted odds ratios (95% confidence intervals) by <italic>APOE</italic> genotype from ordered logistic regression, with quartiles of CRP concentrations as dependent variable; pooled data from men and women</p>
      </caption>
      <table frame="hsides" rules="groups">
        <thead>
          <tr>
            <th align="left"><italic>APOE</italic> genotype</th>
            <th align="left">N</th>
            <th align="left">%</th>
            <th align="left">Crude OR (95% CI)</th>
            <th align="left">Adjusted OR (95% CI)<xref rid="tblfn2" ref-type="table-fn">a</xref></th>
          </tr>
        </thead>
        <tbody>
          <tr>
            <td align="left">All subjects</td>
            <td align="right">6230</td>
            <td align="right">100</td>
            <td/>
            <td align="left">&#x2014;</td>
          </tr>
          <tr>
            <td align="left">22</td>
            <td align="right">42</td>
            <td align="right">0.7</td>
            <td align="char">0.71&#xA0;(0.40&#x2013;1.24)</td>
            <td align="char">0.58&#xA0;(0.31&#x2013;1.08)</td>
          </tr>
          <tr>
            <td align="left">32</td>
            <td align="right">708</td>
            <td align="right">11.4</td>
            <td align="char">0.92&#xA0;(0.80&#x2013;1.06)</td>
            <td align="char">0.92&#xA0;(0.79&#x2013;1.07)</td>
          </tr>
          <tr>
            <td align="left">33</td>
            <td align="right">4126</td>
            <td align="right">66.2</td>
            <td align="char">1.0&#xA0;(reference)</td>
            <td align="char">1.0&#xA0;(reference)</td>
          </tr>
          <tr>
            <td align="left">42</td>
            <td align="right">122</td>
            <td align="right">1.9</td>
            <td align="char">1.03&#xA0;(0.75&#x2013;1.42)</td>
            <td align="char">1.05&#xA0;(0.75&#x2013;1.48)</td>
          </tr>
          <tr>
            <td align="left">43</td>
            <td align="right">1155</td>
            <td align="right">18.5</td>
            <td align="char">0.73&#xA0;(0.65&#x2013;0.83)</td>
            <td align="char">0.69&#xA0;(0.61&#x2013;0.78)</td>
          </tr>
          <tr>
            <td align="left">44</td>
            <td align="right">77</td>
            <td align="right">1.2</td>
            <td align="char">0.50&#xA0;(0.33&#x2013;0.76)</td>
            <td align="char">0.47&#xA0;(0.30&#x2013;0.73)</td>
          </tr>
          <tr>
            <td align="left">33</td>
            <td align="right">4126</td>
            <td align="right">66.2</td>
            <td align="left">1.0</td>
            <td align="char">1.0&#xA0;(reference)</td>
          </tr>
          <tr>
            <td align="left">22&#xA0;+&#xA0;32</td>
            <td align="right">750</td>
            <td align="right">12.1</td>
            <td align="char">0.91&#xA0;(0.79&#x2013;1.04)</td>
            <td align="char">0.90&#xA0;(0.78&#x2013;1.04)</td>
          </tr>
          <tr>
            <td align="left">43&#xA0;+&#xA0;44</td>
            <td align="right">1232</td>
            <td align="right">19.8</td>
            <td align="char">0.72&#xA0;(0.64&#x2013;0.81)</td>
            <td align="char">0.67&#xA0;(0.60&#x2013;0.76)</td>
          </tr>
          <tr>
            <td align="left">42</td>
            <td align="right">122</td>
            <td align="right">1.9</td>
            <td align="char">1.03&#xA0;(0.75&#x2013;1.42)</td>
            <td align="char">1.05&#xA0;(0.75&#x2013;1.48)</td>
          </tr>
        </tbody>
      </table>
      <table-wrap-foot>
        <fn id="tblfn2">
          <label>a</label>
          <p>adjusted for age, sex, total cholesterol, hypertension, body mass index, smoking, and history of angina, myocardial infarction and stroke.</p>
        </fn>
      </table-wrap-foot>
    </table-wrap>
  </floats-wrap>
</article>
